Endovastec?’s Minos? Receives CE MDR Certification and Gains Market Approval in Egypt
15 May 2025
The Minos? Abdominal Aortic Stent Graft and Delivery System (Minos?), developed by Endovastec?, recently received CE MDR (Medical Device Regulation (EU) 2017/745) certification and market approval in Egypt - a milestone in its global market expansion.
Minos? was previously certified under the former CE MDD (Medical Device Directive 93/42/EEC). Designed for endovascular treatment of abdominal aortic aneurysms with a proximal neck length ≥15 mm, Minos? offers strong performance in complex anatomies, including short or angulated necks and narrowed or tortuous access vessels. The device is currently in clinical use across 26 countries.
Endovastec? remains committed to advancing its globalization strategy by delivering high-quality, innovative products to more countries, enhancing access and improving outcomes for patients with aortic and peripheral vascular diseases worldwide.